![ML-290 0191584 maleate 2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M27312_1635994369.gif?v=1635994371)
Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated
(E/Z)-4-Hydroxytamoxifen is an estrogen receptor modulator
1964 and launched by Merck Sharp and Dohme under the trade name Cosmegen
CDK9-PROTAC is a cereblon mediated proteasomal degrader of CDK9
a novel aniline compound
ML-290 0191584 maleate 2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/RonML 290 is a first in class and potent relaxin insulin like family peptide receptor (RXFP1) agonist and activator of anti fibrotic genes, with an EC50 of 94 nM. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1. Product information CAS Number: 1482500 76 4 Molecular Weight: 506. 49 Formula: C24H21F3N2O5S Chemical Name: 2 (propan 2 yloxy) N {2 [(3 trifluoromethanesulfonylphenyl)carbamoyl]phenyl}benzamide Smiles: